Pretzel Therapeutics
Latest round
- Series A
Last raised
- Sep 2022
Total raised
- $66M
Investors
- 11
About Pretzel Therapeutics
, provides therapies to reverse mitochondrial dysfunction by mitochondrial biology. The company offers various mitochondrial therapeutic solutions that include genome correction, genome expression modulation, and mitochondrial quality control used for the treatment of mitochondrial dysfunction. The company used gene-editing tools, DNA replication, transcription, and translation to apply therapy for genetic disorders caused by mitochondrial mutations.
Who invested in Pretzel Therapeutics
11 investors across 1 round
See all investors in Pretzel Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 12, 2022
Amount
$66M
Investors
Questions about Pretzel Therapeutics
Who invested in Pretzel Therapeutics?
Pretzel Therapeutics has 11 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pretzel Therapeutics raised?
Pretzel Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Pretzel Therapeutics last raise money?
Pretzel Therapeutics's most recent round on record is a Series A, in Sep 2022.
What does Pretzel Therapeutics do?
, provides therapies to reverse mitochondrial dysfunction by mitochondrial biology.
Where is Pretzel Therapeutics headquartered?
Pretzel Therapeutics is headquartered in Waltham, US.
Which VCs invest in companies like Pretzel Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pretzel Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Pretzel Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.